Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF426 divergent transcript (ZNF426-DT), also known as CTC-543D15.8, is classified as a long non-coding RNA (lncRNA). It does not encode a protein and is not currently characterized as a therapeutic target, receptor, enzyme, transporter, or transcription factor. There is limited information on its specific biological function, involvement in disease, or potential as a biomarker or drug target in major annotation resources. ZNF426-DT is annotated as a lncRNA gene, located on chromosome 19 (chr19:9538665-9539742, hg38). No protein-coding function or established role as a receptor, enzyme, or other classical drug target type is currently assigned. There are no known drugs, biomarkers, or associated mechanisms of action listed for this gene in primary gene-centric databases. While ZNF426 (Zinc Finger Protein 426) is a protein-coding gene functioning as a transcriptional repressor, ZNF426-DT is a distinct non-coding transcript overlapping or near the ZNF426 locus, and should not be confused with the protein-coding gene. ZNF426 divergent transcript (ZNF426-DT; CTC-543D15.8) is a long non-coding RNA, with no current evidence supporting its use as a therapeutic target, association with disease, or function as a receptor, enzyme, transporter, or transcription factor according to the main available resources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF426 divergent transcript (ZNF426-DT).